Nemonoxacin not checked

TaiGen Biotechnology Co., Ltd. · TG-873870

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
4 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Community-acquired Pneumonia (2 trials), Diabetic Foot Infections, Pneumonia
Main trialPhase 4
“This study was to evaluate the safety and efficacy of oral nemonoxacin in treating elderly patients (aged ≥ 65 years) with community-acquired pneumonia (CAP).”In the company’s words, NCT05133752 on ClinicalTrials.gov
Other names
Taigexyn infusion solution · TG-873870 · Taigexyn

Other drugs for Community-acquired Pneumonia

All 3 drugs for Community-acquired Pneumonia

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials4

TrialPhaseCompletesWhat it tests
Phase 4Completed 23 Mar 2020 Oral Nemonoxacin in Treating Elderly Patients With CAP
Phase 3Completed 4 May 2017 A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAP
Phase 2Completed Apr 2009 Safety and Efficacy Study of TG-873870 (Nemonoxacin) in Diabetic Foot Infections
Phase 2Completed Dec 2013 Study to Evaluate the Efficacy and Safety of Intravenous Infusion With Nemonoxacin Malate Sodium Chloride
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Nemonoxacin

Following is part of Solo: you see every change to Nemonoxacin the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in